Showing results (321-330 of 371) with videos related to
Sort By:
Pageof 38
The New England Journal of Medicine|June 7, 1979
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapyT S Herman, L H Einhorn, S E Jones, et al.Cell Death & Disease|February 15, 2014
Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen speciesS U Kang, J-H Cho, J W Chang, et al.Biochemical and Biophysical Research Communications|February 19, 2000
Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localizationZ H Xu, D M Otterness, R R Freimuth, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|June 30, 2025
Ultrasound detection of lymphatic bubbles in a porcine dive modelJoshua B Currens, Richard E Moon, Matthew S Makowski, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|September 17, 2016
Assessment of the interaction of hyperbaric N2, CO2, and O2 on psychomotor performance in diversJ J Freiberger, B J Derrick, M J Natoli, et al.Blood|May 24, 2003
Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusionJerry S Powell, Margaret V Ragni, Gilbert C White, et al.Anesthesia and Analgesia|May 1, 2014
Reduced length of hospital stay in colorectal surgery after implementation of an enhanced recovery protocolTimothy E Miller, Julie K Thacker, William D White, et al.Lancet (London, England)|June 28, 2002
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trialRobert J Lederman, Farrell O Mendelsohn, R David Anderson, et al.Journal of Nanoscience and Nanotechnology|December 4, 2008
Electrical characterization of ZnO single nanowire device for chemical sensor applicationE K Kim, H Y Lee, S E Moon, et al.Journal of Cardiovascular Pharmacology and Therapeutics|April 17, 2014
Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE studyAntonio M Gotto, Uma Kher, Manash Shankar Chatterjee, et al.Pageof 38